Welcome to our dedicated page for CNFRZ SEC filings (Ticker: CNFRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CNFRZ's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CNFRZ's regulatory disclosures and financial reporting.
Presurance Holdings, Inc. Chief Executive Officer Brian J. Roney reported an open-market purchase of 100,000 shares of common stock. The shares were bought at a weighted average price of $0.7181 per share, in multiple trades priced between $0.54 and $0.78. Following this transaction, he directly owned 510,232 common shares.
Presurance Holdings reported a weak fourth quarter of 2025 as it continues to exit legacy commercial lines. The company posted a net loss allocable to common shareholders of $17.0 million, or $(1.39) per diluted share, on total revenue and other income of $4.6 million. Gross written premiums for the quarter fell to $7.9 million from $13.7 million, reflecting the runoff of underperforming commercial business.
Results for the full year were also negative. Net loss allocable to common shareholders was $18.4 million, or $(1.51) per share, and adjusted operating loss was $25.6 million, or $(2.10) per share. The consolidated combined ratio reached 333.5% in the quarter and 168.8% for the year, indicating heavy underwriting losses. Book value per common share declined to $0.73 from $1.76 as of year-end, while personal lines gross written premiums grew 12.7% in 2025 to $51.1 million and represented 100% of fourth-quarter gross written premium.
Presurance Holdings, Inc. has been notified by Nasdaq that its common stock no longer meets the minimum bid price requirement because the closing bid has stayed below $1.00 per share for 30 consecutive business days. The company has until August 31, 2026 to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days.
If it fails to do so, Presurance may qualify for an additional 180 days if it meets other Nasdaq listing standards and formally commits to curing the deficiency. Shareholders previously approved a reverse stock split in June 2025 at a ratio between 1-for-2 and 1-for-12, and the board can choose the exact ratio any time before June 3, 2026, but plans to use this tool only if it believes it is in shareholders’ best interests. If compliance is not restored, Nasdaq could move to delist the common stock, which the company would be able to appeal.
Presurance Holdings, Inc. reported that 10% owner Clarkston Ventures, LLC exercised subscription rights in an out-of-the-money derivative transaction. Clarkston exercised 3,735,769 subscription rights at $0.00 per right and received 4,277,455 shares of common stock at $1.00 per share.
After the transaction, Clarkston reported owning 8,013,224 shares of Presurance common stock directly. A footnote states that Clarkston disclaims beneficial ownership of all shares held in client accounts.
Presurance Holdings, Inc. received an updated Schedule 13D/A from the Clarkston group detailing a highly concentrated ownership and several financing transactions. Clarkston Ventures, LLC reports beneficial ownership of 8,013,224 common shares, or 26.5% of the class. Clarkston Companies, Inc. reports beneficial ownership of 13,065,360 common shares (including 4,000,000 shares issuable upon warrant exercise), or 43.2% of the class. Individually, Jeffrey A. Hakala and Gerald W. Hakala are each deemed to beneficially own 21,078,584 shares, or 69.7% of the common stock, together with the Clarkston entities.
The filing explains that Clarkston Companies bought warrants exercisable for 4,000,000 shares at $1.50 per share, expiring January 31, 2027, in a private transaction. The company also sold 1,600 shares of Series C Preferred Stock to Clarkston Companies for $8,000,000; these senior securities carry a 15.0% annual cash dividend and strong protective voting rights on changes that affect their terms. In a rights offering where each common holder received one right per share, allowing purchase of 1.145 common shares at $1.00 up to 14,000,000 shares total, Clarkston Ventures acquired 4,277,455 shares and Clarkston Companies acquired 9,065,360 shares under a backstop agreement. The issuer then redeemed all Series B Preferred Stock from Clarkston Companies for $7,500,000, partly offsetting the backstop purchase price.
Presurance Holdings, Inc. insider Clarkston Companies, Inc., a 10% owner, reported major share activity. On February 27, 2026, it made an open-market purchase of 9,065,360 shares of common stock at $1.00 per share, leaving the same number of common shares owned afterward.
On the same date, all 1,500 shares of Series B preferred stock held by Clarkston were redeemed and repurchased by Presurance for a per-share price equal to the $5,000 issue price plus $101.30 of accrued and unpaid dividends. Earlier, on December 23, 2025, Clarkston bought 1,600 shares of Series C preferred stock at $5,000 per share.
Presurance Holdings, Inc. completed a rights offering and related financing that raised an aggregate of $14,000,000 in gross proceeds from subscribers and backstop purchasers. Investors exercised rights to buy 4,284,640 common shares at $1.00 per share, and backstop purchasers acquired 9,715,360 additional shares.
The company used a substantial portion of the proceeds to repurchase and redeem all outstanding Series B Preferred Stock from an affiliate of a board member for an aggregate redemption price of $7.5 million, including accrued dividends, and to pay all accrued preferred dividends. Remaining funds are earmarked for general corporate purposes. Presurance also filed a Certificate of Correction to the Series B designation and amended an existing warrant to correct errors and limit holder rights.
Presurance Holdings, Inc. plans a rights offering of up to 14,000,000 shares of common stock at $1.00 per share, distributed as non-transferable subscription rights to existing shareholders. Holders receive one right for each share owned on February 6, 2026, with each right allowing the purchase of 1.145 shares.
The rights offering is expected to raise approximately $14.0 million in gross proceeds, which the company intends to use primarily to repurchase or redeem all of its Series B Preferred Stock and for general corporate purposes, including debt reduction. The offer expires on February 24, 2026, and is fully backstopped by Clarkston Companies, Inc. and affiliates, which could increase their ownership and influence.
Presurance reports that its historical specialty commercial lines are in run-off, with continued exposure to loss reserve development and a preliminary expectation of up to $5.0 million in additional reserve strengthening for prior loss years at December 31, 2025. The company also highlights a $6.3 million contingent consideration from the CIS sale that may not be realized, and notes that failure to complete the rights offering could affect its ability to address $7.5 million of Series B Preferred Stock due December 31, 2026. Shareholders who do not fully participate face dilution, and the subscription price may be above future trading prices.